103 research outputs found
Assessed and discharged - diagnosis, mortality and revisits in short-term emergency department contacts
BACKGROUND: Emergency departments (EDs) experience an increasing number of patients. High patient flow are incentives for short duration of ED stay which may pose a challenge for patient diagnostics and care implying risk of ED revisits or increased mortality. Four hours are often used as a target time to decide whether to admit or discharge a patient. OBJECTIVE: To investigate and compare the diagnostic pattern, risk of revisits and short-term mortality for ED patients with a length of stay of less than 4 h (visits) with 4–24 h stay (short stay visits). METHODS: Population-based cohort study of patients contacting three EDs in the North Denmark Region during 2014–2016, excluding injured patients. Main diagnoses, number of revisits within 72 h of the initial contact and mortality were outcomes. Data on age, sex, mortality, time of admission and ICD-10 diagnostic chapter were obtained from the Danish Civil Registration System and the regional patient administrative system. Descriptive statistics were applied and Kaplan Meier mortality estimates with 95% CI were calculated. RESULTS: Seventy-nine thousand three hundred forty-one short-term ED contacts were included, visits constituted 60%. Non-specific diagnoses (i.e. symptoms and signs and other factors) were the most frequent diagnoses among both visits and short stay visits groups (67% vs 49%). Revisits were more frequent for visits compared to short stay visits (5.8% vs 4.2%). Circulatory diseases displayed the highest 0–48-h mortality within the visits and infections in the short stay visits (11.8% (95%CI: 10.4–13.5) and (3.5% (95%CI: 2.6–4.7)). 30-day mortality were 1.3% (95%CI: 1.2–1.5) for visits and 1.8% (95%CI: 1.7–2.0) for short stay visits. The 30-day mortality of the ED revisits with an initial visit was 1.0% (0.8–1.3), vs 0.7% (0.7–0.8) for no revisits, while 30-day mortality nearly doubled for ED revisits with an initial short stay visit (2.5% (1.9–3.2)). CONCLUSIONS: Most patients were within the visit group. Non-specific diagnoses constituted the majority of diagnoses given. Mortality was higher among patients with short stay visits but increased for both groups with ED revisits. This suggest that diagnostics are challenged by short time targets
Sister Mary Joseph's Nodule at a University Teaching Hospital in Northwestern Tanzania: A Retrospective Review of 34 cases.
Sister Mary Joseph's nodule is a metastatic tumor deposit in the umbilicus and often represents advanced intra-abdominal malignancy with dismal prognosis. There is a paucity of published data on this subject in our setting. This study was conducted to describe the clinicopathological presentation and treatment outcome of this condition in our environment and highlight challenges associated with the care of these patients, and to proffer solutions for improved outcome. This was a retrospective study of histologically confirmed cases of Sister Mary Joseph's nodule seen at Bugando Medical Centre between March 2003 and February 2013. Data collected were analyzed using descriptive statistics. A total of 34 patients were enrolled in the study. Males outnumbered females by a ratio of 1.4:1. The vast majority of patients (70.6%) presented with large umbilical nodule > 2 cm in size. The stomach (41.1%) was the most common location of the primary tumor. Adenocarcinoma (88.2%) was the most frequent histopathological type. Most of the primary tumors (52.9%) were poorly differentiated. As the disease was advanced and metastatic in all patients, only palliative therapy was offered. Out of 34 patients, 11 patients died in the hospital giving a mortality rate of 32.4%. Patients were followed up for 24 months. At the end of the follow-up period, 14(60.9%) patients were lost to follow-up and the remaining 9 (39.1%) patients died. Patients survived for a median period of 28 weeks (range, 2 to 64 weeks). The nodule recurred in 6 (26.1%) patients after complete excision. Sister Mary Joseph's nodule of the umbilicus is not rare in our environment and often represents manifestation of a variety of advanced intra-abdominal malignancies. The majority of the patients present at a late stage and many with distant metastases. The patient's survival is very short leading to a poor outcome. Early detection of primary cancer at an early stage may improve the prognosis
A non-catecholamine-producing sympathetic paraganglioma of the spermatic cord: the importance of performing candidate gene mutation analysis
textabstractBackground: Catecholamine-producing tumours are called pheochromocytomas when they are located in the adrenal gland and sympathetic paragangliomas when they are located elsewhere in the abdomen. Rarely these tumours do not produce catecholamines and even more rarely they arise in the spermatic cord. Over the past decade, systematic mutation analysis of apparently sporadic cases of pheochromocytomas and paragangliomas has elucidated the frequent presence of germ line mutations in one of five candidate genes, including RET, VHL, SDHB, SDHC, and SDHD. Clinical history and methods: We describe a 45-year-old man with a non catecholamine-producing paraganglioma of the spermatic cord. We performed SDHB immunohistochemistry and performed mutation analysis of the SDHB, SDHC, and SDHD genes. Results: There was no staining of tumour cells with SDHB immunohistochemistry, indicative of an SDH mutation. Mutation analysis demonstrated a germ line SDHD mutation (p.Val147Met). Conclusions: Systematic mutation analysis is required in paraganglioma patients for the detection of germ line mutations. This should be preceded by SDHB immunohistochemistry to limit the number of genes to be tested
Magnetodielectric effect of Graphene-PVA Nanocomposites
Graphene-Polyvinyl alcohol (PVA) nanocomposite films with thickness were synthesized by solidification of PVA in a solution with dispersed
graphene nanosheets. Electrical conductivity data were explained as arising due
to hopping of carriers between localized states formed at the graphene-PVA
interface. Dielectric permittivity data as a function of frequency indicated
the occurrence of Debye-type relaxation mechanism. The nanocomposites showed a
magnetodielectric effect with the dielectric constant changing by 1.8% as the
magnetic field was increased to 1 Tesla. The effect was explained as arising
due to Maxwell-Wagner polarization as applied to an inhomogeneous
two-dimensional,two-component composite model. This type of nanocomposite may
be suitable for applications involving nanogenerators.Comment: 13 pages, 11 figure
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.
PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks
Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study
PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks
Effect of BRAFmutational status on expression profiles in conventional papillary thyroid carcinomas
Sister Mary Joseph's nodule of the umbilicus: Is it always of gastric origin? A review of eight cases at different sites of origin
Objective : The aim of this analysis was to evaluate our management and
outcome of eight cases of Sister Mary Joseph\u2032s Nodule of the
umbilicus (SMJN). Methods : Between 2002 and 2009, we collected eight
cases of SMJN and their clinical data were studied in a retrospective
manner. Results : The mean age of the patients was 50.6 years (range,
34-58). There were three males and five females. Five cases were
discovered preoperatively during an abdominal examination and in the
remaining three patients, the umbilical nodule was noticed during
surgery. Most patients presented with abdominal pain. Various signs
were discovered during clinical examination. Exhaustive investigations
done included ultrasound, computed tomography, magnetic resonance
imaging, endoscopic retrograde cholangiopancreatography, magnetic
resonance cholangiopancreatography, gastrointestinal endoscopy,
mammogram, bone scan, and a panel of tumor markers. The primary tumors
were gastric adenocarcinoma (two patients), ovarian adenocarcinoma (two
patients), pancreatic carcinoma (one patient), colonic adenocarcinoma
(one patient), gallbladder adenocarcinoma (one patient), and
cholangiocarcinoma (one patient). As the disease was advanced and
metastatic in all patients, only palliative therapy was offered. All
patients died within a short period after clinical presentation,
ranging from four to 58 weeks (mean, 20 weeks). Conclusion : SMJN is a
rare manifestation of a variety of advanced malignancies, usually of
gastrointestinal origin. A majority of the patients present at a late
stage and many harbor distant metastases. The patient\u2032s survival
is very short (mean, 20 weeks) leading to a poor outcome. We believe
that if the primary cancer is discovered at an early stage, the
prognosis may improve
Sister Mary Joseph's nodule of the umbilicus: Is it always of gastric origin? A review of eight cases at different sites of origin
Objective : The aim of this analysis was to evaluate our management and
outcome of eight cases of Sister Mary Joseph′s Nodule of the
umbilicus (SMJN). Methods : Between 2002 and 2009, we collected eight
cases of SMJN and their clinical data were studied in a retrospective
manner. Results : The mean age of the patients was 50.6 years (range,
34-58). There were three males and five females. Five cases were
discovered preoperatively during an abdominal examination and in the
remaining three patients, the umbilical nodule was noticed during
surgery. Most patients presented with abdominal pain. Various signs
were discovered during clinical examination. Exhaustive investigations
done included ultrasound, computed tomography, magnetic resonance
imaging, endoscopic retrograde cholangiopancreatography, magnetic
resonance cholangiopancreatography, gastrointestinal endoscopy,
mammogram, bone scan, and a panel of tumor markers. The primary tumors
were gastric adenocarcinoma (two patients), ovarian adenocarcinoma (two
patients), pancreatic carcinoma (one patient), colonic adenocarcinoma
(one patient), gallbladder adenocarcinoma (one patient), and
cholangiocarcinoma (one patient). As the disease was advanced and
metastatic in all patients, only palliative therapy was offered. All
patients died within a short period after clinical presentation,
ranging from four to 58 weeks (mean, 20 weeks). Conclusion : SMJN is a
rare manifestation of a variety of advanced malignancies, usually of
gastrointestinal origin. A majority of the patients present at a late
stage and many harbor distant metastases. The patient′s survival
is very short (mean, 20 weeks) leading to a poor outcome. We believe
that if the primary cancer is discovered at an early stage, the
prognosis may improve
- …